RCAR Stock Price, Chart, Stats & News

RenovaCare, Inc.
Save
RenovaCare, Inc. (RCAR) does not currently pay a dividend.
8,735
Market cap
–
Current P/E
–
Forward P/E
RCAR chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs.
Similar securities
Based on sector and market capitalization
Report issue





